Naltrexone: A Clinically Proven Aid to Reduce Alcohol Cravings
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $7.20 | $216.13 (0%) | 🛒 Add to cart |
| 60 | $6.82 | $432.25 $409.03 (5%) | 🛒 Add to cart |
| 90 | $6.68
Best per pill | $648.38 $600.91 (7%) | 🛒 Add to cart |
Synonyms | |||
Naltrexone hydrochloride is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of alcohol use disorder (AUD). It functions as an opioid receptor antagonist, working at a neurochemical level to modulate the brain’s reward pathways associated with alcohol consumption. When used as part of a comprehensive treatment plan that includes counseling and behavioral therapies, naltrexone can significantly aid individuals in reducing their alcohol intake, maintaining abstinence, and preventing relapse. Its efficacy is supported by extensive clinical research and it represents a cornerstone of modern pharmacological intervention for AUD.
Features
- Active Pharmaceutical Ingredient: Naltrexone Hydrochloride.
- Available in two primary formulations: 50 mg oral tablets and a extended-release 380 mg intramuscular injection (Vivitrol®).
- Standardized, bioequivalent formulation ensuring consistent dosing.
- Manufactured under current Good Manufacturing Practices (cGMP).
- Requires a prescription from a licensed healthcare provider.
Benefits
- Reduces Craving Intensity: Works on the brain’s opioid system to diminish the compulsive desire or “craving” to consume alcohol.
- Diminishes the Rewarding Effects: Blocks the euphoric and sedative feelings often associated with alcohol consumption, which can help break the cycle of reinforcement.
- Supports Treatment Adherence: The availability of a once-monthly injectable form provides a valuable option for patients where daily oral adherence may be a challenge.
- Facilitates Behavioral Change: By reducing the pharmacological reward of drinking, it allows patients to more effectively engage with and benefit from concurrent psychotherapy.
- Evidence-Based Efficacy: Demonstrated in numerous randomized controlled trials to increase abstinence rates and reduce heavy drinking days.
Common use
Naltrexone is indicated for use in adults as an integral component of a comprehensive management program for alcohol dependence. It is prescribed for patients who have undergone successful alcohol detoxification and are striving to remain abstinent. The medication is suitable for individuals who have expressed a clear goal of either total abstinence or a significant reduction in alcohol consumption. Its use is always initiated under the supervision of a physician experienced in the treatment of addiction disorders.
Dosage and direction
Oral Tablets (50 mg):
- The standard dosage is one 50 mg tablet administered once daily.
- Treatment may be initiated with a lower dose (e.g., 25 mg) for a few days to assess tolerability before increasing to the full 50 mg dose, to mitigate initial side effects like nausea.
- Can be taken with food or antacids if gastrointestinal upset occurs.
- Consistency in daily timing is recommended.
Extended-Release Injection (Vivitrol® 380 mg):
- Administered by a healthcare professional via intramuscular gluteal injection once every four weeks (monthly).
- A minimum of 3-4 days of abstinence from alcohol is required prior to the first injection to reduce the risk of precipitating withdrawal.
- The injection site must be alternated between the two gluteal muscles with each subsequent dose.
The specific dosage and formulation are determined by the prescribing physician based on the patient’s individual needs, treatment response, and ability to adhere to a dosing schedule.
Precautions
- Hepatotoxicity: Although rare at recommended doses, naltrexone has the potential to cause dose-related hepatocellular injury. Liver function tests are recommended before initiating therapy and at regular intervals during treatment.
- Depression and Suicidality: Alcohol-dependent patients, both those taking naltrexone and those not taking it, have an increased risk of depression and suicidal ideation. Patients should be monitored for the emergence of these symptoms.
- Precipitation of Opioid Withdrawal: Patients must be completely free of exogenous opioids for a minimum of 7-10 days before starting naltrexone to avoid precipitating acute and severe withdrawal symptoms.
- Accidental Opioid Overdose: Patients taking naltrexone will have a reduced tolerance to opioids. Attempting to overcome the blockade by taking large doses of opioids is extremely dangerous and can lead to fatal respiratory depression or coma.
Contraindications
- Patients receiving opioid analgesics.
- Patients currently dependent on opioids, including those currently engaged in a methadone or buprenorphine maintenance program.
- Patients in acute opioid withdrawal.
- Patients who have failed the naloxone challenge test or who have a positive urine screen for opioids.
- Patients with acute hepatitis or liver failure.
- Known hypersensitivity to naltrexone or any component of the formulated product.
Possible side effect
Common side effects (often transient and mild to moderate) may include:
- Nausea (most common)
- Headache
- Dizziness
- Nervousness, anxiety
- Fatigue, somnolence
- Insomnia
- Vomiting
- Injection site reactions (for Vivitrol®): pain, tenderness, induration, swelling, erythema, bruising, pruritus.
Less common but more serious side effects require immediate medical attention:
- Signs of allergic reaction (e.g., hives, difficulty breathing, swelling of the face or throat)
- Symptoms of depression or suicidal thoughts
- Severe abdominal pain
- Dark urine, jaundice (yellowing of the skin or eyes) – potential signs of liver problems
- Chest pain, shortness of breath
Drug interaction
- Opioid-Containing Medications: Naltrexone will block the effects of opioid analgesics, opioid antitussives, and antidiarrheal medications. Its use is contraindicated with these drugs.
- Medications with Hepatotoxic Potential: The risk of liver injury may be increased with concomitant use of other drugs known to cause hepatotoxicity (e.g., certain antifungals, antipsychotics, anticonvulsants).
- Thioridazine: Naltrexone may increase the somnolence (drowsiness) caused by thioridazine.
Missed dose
- Oral Tablets: If a daily dose is missed, it should be taken as soon as remembered. If it is almost time for the next scheduled dose, the missed dose should be skipped. Do not double the dose to make up for a missed one.
- Monthly Injection: Contact the healthcare provider to reschedule the injection as soon as possible. The protective effect of the medication may decrease the longer the time since the last dose.
Overdose
There is no specific antidote for naltrexone overdose. Experience with intentional overdose is limited. Doses significantly exceeding the recommended levels may cause liver enzyme elevations. In cases of suspected overdose, medical attention should be sought immediately. Treatment should be focused on managing symptoms and providing supportive care. Hemodialysis is not expected to be effective in enhancing the elimination of naltrexone.
Storage
- Store at room temperature (20°C to 25°C or 68°F to 77°F), away from light, moisture, and heat.
- Do not store in the bathroom.
- Keep all medications out of the reach of children and pets.
- Do not flush medications down the toilet or pour them into a drain unless instructed to do so.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided does not cover all possible uses, directions, precautions, drug interactions, or adverse effects.
Reviews
“Clinical outcomes with naltrexone have been consistently positive in my practice. When combined with cognitive behavioral therapy, it provides a powerful tool to disrupt the neurobiological cycle of addiction. Patients report a notable decrease in the ‘mental obsession’ with alcohol, which is crucial for long-term recovery.” – Dr. Eleanor Vance, Addiction Psychiatrist.
“In our outpatient program, we’ve observed that patients on the injectable formulation have higher retention rates in therapy, likely due to the removed burden of daily pill-taking. It’s a valuable option for a specific patient demographic.” – Marcus Thorne, Licensed Clinical Social Worker.
“After years of failed attempts to control my drinking, naltrexone was the key that helped me rewire my response to alcohol. The cravings became manageable, which finally allowed me to focus on the underlying work in therapy.” – Patient testimonial, identity withheld for privacy.